ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

BACKGROUND: Cholangiocarcinoma (CHOL) is the second most common primary hepatic malignant tumor, following hepatocellular carcinoma (HCC). CHOL is highly aggressive and heterogeneous resulting in poor prognosis. The diagnosis and prognosis of CHOL has not improved in the past decade. Acyl-CoA synthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuochen, Fan, Shilong, Wang, Yirui, Chen, Ruixiang, Wang, Ziyi, Zhang, Yaodong, Jiang, Wangjie, Chen, Yananlan, Xu, Xiao, Yu, Yue, Li, Changxian, Li, Xiangcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186676/
https://www.ncbi.nlm.nih.gov/pubmed/37193981
http://dx.doi.org/10.1186/s12885-023-10903-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186676/
https://www.ncbi.nlm.nih.gov/pubmed/37193981
http://dx.doi.org/10.1186/s12885-023-10903-5

Ejemplares similares